Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma

Treatment resistance is observed in all advanced cancers. Colorectal cancer (CRC) presenting as colorectal adenocarcinoma (COAD) is the second leading cause of cancer deaths worldwide. Multimodality treatment includes surgery, chemotherapy, and targeted therapies with selective utilization of immuno...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kshama Gupta, Jeremy C. Jones, Virginea De Araujo Farias, Yuri Mackeyev, Pankaj K. Singh, Alfredo Quiñones-Hinojosa, Sunil Krishnan
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2022-05-01
Серии:Frontiers in Oncology
Предметы:
KRAS
DDR1
BCR-ABL1
COAD
GBM
chemoradioresistance
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fonc.2022.840241/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы